Diagnos $ADK $DGNOF Initiates a Clinical Trial Study in the USA for Early Detection and Prevention of Stroke Using it new Application CARA-STROKE

Diagnos Inc. (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues, announces today the initiation of a clinical trial study with CommonSpirit Health Research Institute, Chattanooga Center for Neurologic Research LLC and conducted at the CommonSpirit Hospital in Chattanooga, to confirm early Proof-of-Concept results that showed a strong potential in… Continue reading Diagnos $ADK $DGNOF Initiates a Clinical Trial Study in the USA for Early Detection and Prevention of Stroke Using it new Application CARA-STROKE